Trial Summary
What is the purpose of this trial?
This trial tests a treatment that combines personalized advice with supportive text messages for young adults in a psychiatric program who drink to cope with negative emotions. The goal is to provide real-time support to manage emotions and reduce drinking.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the PFIcope+EMI treatment for alcoholism?
Research shows that using personalized feedback and real-time assessments, like those in PFIcope+EMI, can help people reduce their drinking by understanding their motivations and self-confidence. Studies have found that daily tracking of motivation and self-efficacy (belief in one's ability to succeed) can predict drinking behavior, suggesting that these methods can be effective in treating alcohol use disorder.12345
Is PFIcope+EMI safe for humans?
How is the PFIcope+EMI treatment for alcoholism different from other treatments?
Research Team
Ana M Abrantes, Ph.D.
Principal Investigator
Butler Hospital/Alpert Medical School of Brown University
Eligibility Criteria
This trial is for young adults aged 18-25 who drink alcohol heavily at least three times a week and use it to cope with negative feelings. They must have symptoms of anxiety or depression, own a smartphone, but not be currently suicidal or have severe substance use disorders (except for alcohol, cannabis, or nicotine) or psychotic conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 6-week PFIcope+EMI intervention, including personalized feedback sessions, EMA monitoring, and tailored EMI text messages.
Follow-up
Participants are monitored for alcohol outcomes and psychiatric symptomatology at 6-weeks, 12-weeks, and 6-months to determine outcomes and feasibility/acceptability.
Treatment Details
Interventions
- Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI) (Behavioral Intervention)
- Personalized Normative Feedback (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Butler Hospital
Lead Sponsor
Matt Schnur
Butler Hospital
Chief Executive Officer
Doctor of Pharmacy from Duquesne University
Dr. Monique Butler
Butler Hospital
Chief Medical Officer since 2018
MD from Wayne State University, MBA from the University of Tennessee
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Dr. George F. Koob
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Executive Officer since 2014
PhD in Neurobiology from the Scripps Research Institute
Dr. Patricia Powell
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Medical Officer since 2015
MD from an accredited institution